Clinical trial NCT06285617 - References

Subacute Thyroiditis — Short-Term Versus 6-Week Prednisone in The Treatment of Subacute Thyroiditis

Citation(s)

•   Alves C, Robazzi TC, Mendonca M
  Withdrawal from glucocorticosteroid therapy: clinical practice recommendations. J Pediatr (Rio J). 2008 May-Jun;84(3):192-202. doi: 10.2223/JPED.1773.
•   Benbassat CA, Olchovsky D, Tsvetov G, Shimon I
  Subacute thyroiditis: clinical characteristics and treatment outcome in fifty-six consecutive patients diagnosed between 1999 and 2005. J Endocrinol Invest. 2007 Sep;30(8):631-5. doi: 10.1007/BF03347442.
•   Broersen LH, Pereira AM, Jorgensen JO, Dekkers OM
  Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2015 Jun;100(6):2171-80. doi: 10.1210/jc.2015-1218. Epub 2015 Apr 6.
•   Duan L, Feng X, Zhang R, Tan X, Xiang X, Shen R, Zheng H
  Short-Term Versus 6-Week Prednisone In The Treatment Of Subacute Thyroiditis: A Randomized Controlled Trial. Endocr Pract. 2020 Aug;26(8):900-908. doi: 10.4158/EP-2020-0096.
•   Kubota S, Nishihara E, Kudo T, Ito M, Amino N, Miyauchi A
  Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan. Thyroid. 2013 Mar;23(3):269-72. doi: 10.1089/thy.2012.0459.
•   Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS
  Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15(4):457-65. doi: 10.1517/14740338.2016.1140743. Epub 2016 Feb 6.
•   Pearce EN, Farwell AP, Braverman LE
  Thyroiditis. N Engl J Med. 2003 Jun 26;348(26):2646-55. doi: 10.1056/NEJMra021194. No abstract available. Erratum In: N Engl J Med. 2003 Aug 7;349(6):620.
•   Waljee AK, Rogers MA, Lin P, Singal AG, Stein JD, Marks RM, Ayanian JZ, Nallamothu BK
  Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017 Apr 12;357:j1415. doi: 10.1136/bmj.j1415.

Short-Term Versus 6-Week Prednisone in The Treatment of Subacute Thyroiditis: An Open-label, Randomized, Controlled, and Multicenter Trial

Details for clinical trial NCT06285617